9527311000001104: Agalsidase beta (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

31076701000001113 Agalsidase beta (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

31076801000001116 Agalsidase beta en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Agalsidase beta	Is a	Beta-galactosidase	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection	Has active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection	Has active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 5mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Agalsidase beta 5mg powder for solution for injection vials 1 vial	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme)	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial	Has specific active ingredient	False	Agalsidase beta	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets